One of the hardest lessons learned occurred after I inadvertently failed at communication and education before transferring a ...

The Soft Tissue Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the ...

The National Strategy for Gene and Cell-based Therapies Funds the University Hospital Regensburg and the Leibniz Institute for Immunotherapy to Advance Cutting-Edge T Cell Therapy for Sarcoma Patients ...

Clear cell sarcoma (CCS), or malignant melanoma of soft parts, is a rare, extremely aggressive soft tissue sarcoma, which accounts for less than 1% of soft tissue sarcomas. Though extremely rare, CCS ...

This study provides useful information by identifying the cell type (macrophages) in synovial tissues involved in the pathogenesis of post-traumatic osteoarthritis (OA) and clarifying distinct ...

These cells have abundant eosinophilic cytoplasm, large nuclei with a vesicular or hyperchromatic appearance, and no mitotic figures. Immunohistochemical markers Calretinin and CK5/6 are positive, ...

called natural killer cells, to target and destroy sarcoma tumors. The treatment could also have an impact on other hard-to-cure diseases such as triple negative breast cancer. Clinical Director ...

QPCR data is presented for each of the clones for osteogenic (B,F), chondrogenic (C,G) and adipogenic (D,H) markers. *p<0.05, **p<0.01 Figure 2. OA scoring with and without cell injection in a rat DMM ...

Early effects of Trabectedin (<12M) include the exhaustion of B cells, activation of T and NK cells, and increase of LIF gene expression associated with control of stemness properties of sarcoma cells ...